Clinical Trials Browser

Interventional × zolbetuximab × 1 year × Clear all

Pancreatic Neoplasms

NCT06901531 2026-03-11

LUCERNA

Phase 3 Recruiting

500 enrolled

Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT07431281 2026-02-24

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Phase 3 Recruiting

2,130 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT03504397 2026-02-13

Spotlight

Phase 3 Active not recruiting

565 enrolled 63 charts 1 FDA

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT03653507 2026-02-06

GLOW

Phase 3 Active not recruiting

507 enrolled 65 charts 1 FDA

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT06468280 2026-01-21

ROSETTE

Phase 2 Recruiting

84 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06962137 2025-12-22

RAINSPOT

Phase 2 Recruiting

100 enrolled

Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

NCT06396091 2025-11-13

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

Phase 1 Active not recruiting

12 enrolled

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT03505320 2025-10-20

ILUSTRO

Phase 2 Active not recruiting

143 enrolled

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT06732856 2025-07-28

NEO-CLAUD

Phase 1/2 Recruiting

57 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01630083 2025-06-15

FAST

Phase 2 Completed

252 enrolled

Gastrointestinal

CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction

NCT01197885 2025-06-13

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

Phase 2 Completed

54 enrolled

Other solid neoplasm

Solid Tumors

Clinical Trials

A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

LUCERNA

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Spotlight

GLOW

ROSETTE

RAINSPOT

A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer

ILUSTRO

NEO-CLAUD

FAST

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer